Dr. Stuart Bond Honoured with President’s Award at 19th World Congress of the International Photodynamic Association

June 13, 2025 05:42 AM AEST | By EIN Presswire
 Dr. Stuart Bond Honoured with President’s Award at 19th World Congress of the International Photodynamic Association
Image source: EIN Presswire
SHANGHAI, CHINA, June 13, 2025 /EINPresswire.com/ -- The International Photodynamic Association (IPA) is pleased to announce that Dr. Stuart Bond, Consultant Antimicrobial Pharmacist and Director of Innovation at Mid Yorkshire Teaching NHS Trust, has been awarded the prestigious President’s Award at the 19th World Congress of the IPA, held this year in Shanghai, China.

The President’s Award is one of the IPA’s highest honours, reserved for individuals whose work is making a transformational impact on healthcare through photodynamic therapy. Dr. Bond received this distinguished honour in recognition of his leadership in advancing the use of antimicrobial photodynamic therapy (aPDT, also known as photodisinfection) for infection prevention within the UK's National Health Service (NHS). His pioneering work led to the first implementation of this innovative technology within the NHS for reducing surgical site infections in joint replacement procedures. The Mid Yorkshire team’s results—including a 71% reduction in surgical site infections for knee and hip replacements—highlight both improved patient outcomes and significant cost savings.

“Dr. Bond and his team at Mid Yorkshire were the first to operationalize antimicrobial photodynamic therapy within the NHS,” said Dr. Colin Hopper, President of the IPA. “Their published findings have not only demonstrated the clinical value of aPDT but have also set a benchmark in infection prevention. Their leadership showcases the importance of photodisinfection in an era of rising multidrug resistance and reinforces the NHS as a global leader in antibiotic stewardship and patient safety.”

Dr. Bond has served as a Consultant Antimicrobial Pharmacist since 2017 and holds a PhD in educational strategies to improve antimicrobial stewardship. He is also a Visiting Fellow at the University of Huddersfield, where he contributes to PhD supervision and teaches pharmacy and non-medical prescribing students at both Huddersfield and the University of Leeds.

Under Dr. Bond’s leadership, the Innovation Group at Mid Yorkshire Teaching NHS Trust has played a pivotal role in evaluating and adopting clinically validated, cost-effective technologies like photodisinfection. These efforts continue to strengthen the Trust’s standing as a centre of excellence in healthcare innovation and antimicrobial stewardship.

The International Photodynamic Association congratulates Dr. Stuart Bond on this well-deserved recognition.



About Photodynamic Therapy

Photodynamic Therapy (PDT) is a combination therapy involving light activated photosensitizers to diagnose and treat various types and stages of cancers and pre-cancers, macular degeneration and multidrug-resistant infections involving bacteria, viruses and fungi.

PDT traces its scientific roots to the early 20th century, when researchers first observed that certain dyes could render cells sensitive to light. Over the decades, PDT has evolved from a laboratory curiosity into a transformative clinical modality, with the first modern clinical applications emerging in the 1970s and 1980s. Since then, PDT has been used to treat a wide range of cancers, pre-cancerous conditions, and infections, with growing applications in ophthalmology and dermatology. The IPA and its members have played a pivotal role in this journey, advancing the science, clinical protocols, and global adoption of PDT, photoimmunotherapy, and photodiagnosis.



About the International Photodynamic Association

Founded in 1986, the International Photodynamic Association (IPA) is a global organization dedicated to advancing the research, education, and clinical use of photodynamic technologies across medical and biological fields. With members in over 30 countries, the IPA brings together a worldwide community of leading scientists, clinical and translational researchers, healthcare professionals, and students from academia, hospitals, government and industry.

The IPA promotes the study and application of light-activated photosensitizers for diagnosis and treatment, and actively disseminates scientific knowledge to its members, the broader research community, and the public. Every two years, the IPA hosts a World Congress—an international forum for sharing the latest developments in photodynamic therapy, photoimmunotherapy, and photodiagnosis.

The work of IPA members continues to improve health outcomes for millions around the world, contributing to the prevention and treatment of cancer, vision loss, and serious infections.

For more information, visit: www.internationalphotodynamic.com

Media Contact:

International Photodynamic Association

[email protected]

Colin Hopper
International Photodynamic Association
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.